Public Relations (PR)

Ascension Health ups Ragone to chief marcomms officer

Ascension Health ups Ragone to chief marcomms officer

By

The Ketchum veteran joined the nonprofit healthcare system in mid-2014.

Johnson & Johnson comms leader stepping down

Johnson & Johnson comms leader stepping down

By

FitzPatrick is departing the company as it evaluates its 150 agency partnerships.

InVentiv Health PR promotes O'Kane to MD

InVentiv Health PR promotes O'Kane to MD

By

Former Biosector 2 US MD Jeanine O'Kane was named inVentiv Health PR Group's US MD.

Weber Shandwick buys healthcare specialist ReviveHealth

Weber Shandwick buys healthcare specialist ReviveHealth

By

Nashville-based ReviveHealth posted $8.7 million in revenue in 2014.

DCI Group aids Turing amid drug price, Shkreli controversies

DCI Group aids Turing amid drug price, Shkreli controversies

By

The firm began working with the pharma company before outrage over its drug pricing but has more recently supported the client after former CEO Martin Shkreli was arrested.

Paul Newman to lead Takeda's vaccines comms

Paul Newman to lead Takeda's vaccines comms

By

The former MSL regional leader reemerges as head of communications at Japan's largest pharma company.

Pfizer taps corporate affairs leads as part of reorganization

Pfizer taps corporate affairs leads as part of reorganization

By

Pfizer selected MacKay Jimeson and Niesha Foster as corporate affairs category leads after a reorganization of the company's global innovative pharma business.

Edelman signs China health comms partnership

Edelman signs China health comms partnership

The agency will team up with Tsinghua Institute of Health Communication on study on how consumers interact with healthcare content.

Why drug companies need to go from reactive to proactive on pricing

Why drug companies need to go from reactive to proactive on pricing

By

Drug pricing has been in the spotlight since early this fall, thanks to Turing Pharmaceuticals and Martin Shkreli. One thing pharma companies can do is to communicate more proactively.

Editor's Desk: Escaping the Shkreli Cycle

Editor's Desk: Escaping the Shkreli Cycle

By

Three suggestions for defusing the highly charged pricing atmosphere

Theranos fights back against scrutinizing WSJ reports with 6,000-word post

Theranos fights back against scrutinizing WSJ reports with 6,000-word post

By

Theranos posted the lengthy response on the news section of its website on Thursday, then bragged on Twitter that its statement was 3,000 words longer than the WSJ story.

Valeant's controversial model undergoing changes, says CEO

Valeant's controversial model undergoing changes, says CEO

By

The drugmaker, which recently drew scrutiny from lawmakers, is planning to change some of its most contentious business practices. Experts say Valeant also needs to educate lawmakers and the public about the value of its medicines.

GCI Health ups Cahill to North America president

GCI Health ups Cahill to North America president

By

Sherry Goldberg will replace her as New York market leader.

Finn Partners names Kuhl senior partner

Finn Partners names Kuhl senior partner

By

Kristie Kuhl, previously EVP at Cohn & Wolfe, is tasked with building out the agency's pharmaceutical business.

Six things for pharma marketers to know: Thursday, October 8, 2015

Six things for pharma marketers to know: Thursday, October 8, 2015

By

Sanofi's Aubagio reduces brain volume loss; cancer specialists avoid pricey cancer meds; analysis says placebo effect is on the rise

New Turing CCO steps down amid drug price controversy

New Turing CCO steps down amid drug price controversy

By

Craig Rothenberg joined Turing as its first comms chief less than two months ago.

Pfizer's Susman: Customer-company relationship has changed

Pfizer's Susman: Customer-company relationship has changed

By

Stakeholder activists, social media and an increasingly global market are three defining issues for companies operating in the 21st century.

WebMD's Holland joins MWW's corporate health practice

WebMD's Holland joins MWW's corporate health practice

Holland most recently worked as executive director of public health solutions at WebMD.

7 questions for new Turing Pharmaceuticals comms chief Craig Rothenberg

7 questions for new Turing Pharmaceuticals comms chief Craig Rothenberg

After two decades at Johnson & Johnson, Craig Rothenberg talks about joining a startup and the role of comms in pharma.

Savvy comms paves way for Walgreens Boots Alliance merger

Savvy comms paves way for Walgreens Boots Alliance merger

Walgreens Boots Alliance's global comms team works hand in hand to balance the complexities of a merger and create a unified strategy to inspire all stakeholders.

Experts: Sprout needs to show Addyi is not Viagra for women

Experts: Sprout needs to show Addyi is not Viagra for women

Contrary to popular belief, Addyi is not the female Viagra. That's the message drug-maker Sprout must get across to doctors and patients in the coming weeks.

ViiV Healthcare hires Porter Novelli for corporate comms

ViiV Healthcare hires Porter Novelli for corporate comms

ViiV Healthcare, a joint venture by Pfizer and GlaxoSmithKline, has appointed Porter Novelli to manage its corporate comms account, PRWeek understands.

Healthcare reimagined: Fortner finesses McKesson's bold vision

Healthcare reimagined: Fortner finesses McKesson's bold vision

From evolving healthcare laws to social engagement, litigation crises to media relations, McKesson's PR chief is hands-on in efforts to enhance the brand's image.

Novartis exec: Pharma culture can be stumbling block to creativity

Novartis exec: Pharma culture can be stumbling block to creativity

By

It's not always regulation or concerns about legal risks. Sometimes, a drugmaker's internal conservative culture is the biggest hurdle to overcome.

Smirnoff switches over to Weber's health practice

Smirnoff switches over to Weber's health practice

By

Weber Shandwick hired Susan Smirnoff away from the healthcare practice of Ruder Finn, where she had spent more than three decades.

Astellas serves up dose of "reality" in DTC effort

Astellas serves up dose of "reality" in DTC effort

By

The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.

Novo, Deen agree to suspend their relationship

Novo, Deen agree to suspend their relationship

By

Novo Nordisk stresses that the company has not parted ways with Paula Deen, even as her other endorsement and business deals shrivel up.

Novo Nordisk in Paula Deen holding pattern

Novo Nordisk in Paula Deen holding pattern

By

The drug maker says it has spoken to Deen about her racist comments, but an opaque company statement indicates the Danish firm has not cut ties with the now-former Food Network star.

It's Consumer's Choices as Guidelines Change

It's Consumer's Choices as Guidelines Change

Welcome to the ambivalent world of healthcare, where confusion reigns as shifts in science and guidelines seemingly raise more questions than they answer.

Business briefs: GlaxoSmithKline, Burson-Marsteller

GSK says 2013 will be a springboard for future growth, Burson-Marsteller hands out two new executive titles.

Email Newsletters